IMATIB 100 MG 10 TABLETS | Imatinib Targeted Cancer Therapy
IMATIB 100 MG 10 TABLETS contain Imatinib Mesylate 100 mg, a prescription targeted anticancer medicine used for certain blood cancers and gastrointestinal stromal tumors under specialist supervision.
IMATIB 100 MG 10 TABLETS
IMATIB 100 MG TABLETS (Imatinib Mesylate 100 mg): Comprehensive Guide and Benefits
Introduction to IMATIB 100 MG TABLETS
Targeted Tyrosine Kinase Inhibitor Therapy for Cancer Management
IMATIB 100 MG TABLETS contain Imatinib Mesylate 100 mg, a prescription targeted anticancer medicine belonging to the class of tyrosine kinase inhibitors (TKIs). It is used in the treatment of specific cancers, including certain types of blood cancers such as chronic myeloid leukemia (CML), some cases of acute lymphoblastic leukemia (ALL), and gastrointestinal stromal tumors (GIST) under the supervision of an oncologist.
Imatinib works by blocking specific abnormal proteins that contribute to cancer cell growth and multiplication, helping slow or stop the progression of certain cancer cells.
Prescription Status: Prescription-only anticancer medicine. Use strictly under the guidance of a qualified oncologist.
Key Benefits of IMATIB 100 MG TABLETS
Helps manage certain types of blood cancers, including chronic myeloid leukemia (CML).
Used in selected cases of acute lymphoblastic leukemia (ALL).
Helps treat gastrointestinal stromal tumors (GIST).
Targets specific cancer-driving enzymes involved in abnormal cell growth.
Supports slowing the growth and spread of certain cancer cells.
Composition
Active Ingredient:
Imatinib Mesylate – Equivalent to Imatinib 100 mg
Dosage Form:
Film-coated Tablet
Pack Size:
10 Tablets
Drug Class:
Tyrosine Kinase Inhibitor (TKI)
Targeted Anticancer Agent
Therapeutic Category:
Oncology / Antineoplastic Medicine
Manufacturer/Marketer:
Cipla Ltd.
How IMATIB 100 MG Works
IMATIB contains Imatinib, which works through targeted action:
1. Blocks Abnormal Tyrosine Kinase Activity
Inhibits enzymes such as BCR-ABL tyrosine kinase, which play a role in the uncontrolled growth of certain leukemia cells.
Helps reduce abnormal cancer cell multiplication.
2. Limits Cancer Cell Growth
Interferes with signals required for cancer cell survival and reproduction.
May promote programmed cell death (apoptosis) in affected cancer cells.
Usage Instructions
Take IMATIB 100 MG TABLETS exactly as prescribed by your oncologist.
Swallow the tablet whole with water.
Take with food to reduce stomach irritation.
Take it at the same time each day for consistent drug levels.
Do not stop or change the dose without medical advice.
Medicinal Advantages
Chronic Myeloid Leukemia (CML) Management
IMATIB is commonly prescribed for Philadelphia chromosome-positive chronic myeloid leukemia, where it targets abnormal BCR-ABL protein activity.
Gastrointestinal Stromal Tumor (GIST)
Imatinib may be used for certain GIST cases where specific molecular changes make the tumor responsive to targeted therapy.
Other Approved Uses
Depending on specialist evaluation, Imatinib may also be used for selected conditions such as:
Acute lymphoblastic leukemia (ALL) with specific genetic markers.
Dermatofibrosarcoma protuberans (DFSP).
Certain bone marrow disorders.
Mechanism of Action
Imatinib is a selective tyrosine kinase inhibitor that:
Blocks BCR-ABL tyrosine kinase activity.
Inhibits signaling pathways responsible for abnormal cancer cell growth.
Reduces proliferation of specific malignant cells.
Promotes apoptosis in targeted cancer cells.
Off-Label Uses
Imatinib may sometimes be considered for other medical conditions based on specialist evaluation and available clinical evidence.
Off-label use should only be undertaken under strict oncologist supervision.
Expert Advice
Regular blood tests may be required to monitor blood cell counts and liver function.
Report unusual swelling, rapid weight gain, bleeding, or signs of infection.
Inform your doctor about all medicines, supplements, and herbal products you use.
Do not discontinue treatment without consulting your oncologist.
Precautions
Liver Function
Inform your doctor if you have liver disease. Liver function monitoring may be required.
Heart and Fluid Retention Risk
Report symptoms such as sudden weight gain, swelling, or breathing difficulty.
Pregnancy and Breastfeeding
Consult your oncologist before use during pregnancy or breastfeeding.
Drug Interactions
Many medicines can affect Imatinib levels; provide your doctor with a complete medication list.
Drug Interactions
Inform your healthcare provider if you take:
Blood thinners.
Certain antibiotics or antifungal medicines.
Seizure medicines.
Herbal supplements.
Other anticancer medicines.
Possible Side Effects
Common side effects may include:
Nausea.
Vomiting.
Diarrhea.
Muscle cramps.
Fatigue.
Headache.
Skin rash.
Abdominal discomfort.
Swelling or fluid retention.
Seek immediate medical advice for severe swelling, unusual bleeding, severe allergic reactions, or signs of infection.
Storage Instructions
Store below 30°C.
Keep tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep away from children.
Frequently Asked Questions (FAQs)
Q: What is IMATIB 100 MG used for?
A: IMATIB 100 MG contains Imatinib Mesylate and is used for certain cancers, including chronic myeloid leukemia (CML), some acute lymphoblastic leukemia cases, and gastrointestinal stromal tumors.
Q: Is IMATIB a chemotherapy medicine?
A: IMATIB is a targeted anticancer therapy called a tyrosine kinase inhibitor. It works differently from traditional chemotherapy by specifically targeting cancer-related proteins.
Q: Can IMATIB 100 MG be stopped suddenly?
A: No. Treatment should only be stopped or changed after consultation with an oncologist.
Q: What is the active ingredient in IMATIB 100 MG?
A: Each tablet contains Imatinib Mesylate equivalent to Imatinib 100 mg.
Q: Should IMATIB be taken with food?
A: Yes. Taking it with food and water may help reduce stomach-related discomfort.
Product Tags
IMATIB 100 MG 10 TABLETS, Imatinib Mesylate 100 mg Tablet, Tyrosine Kinase Inhibitor Medicine, Targeted Cancer Therapy, Chronic Myeloid Leukemia Medicine, GIST Treatment Medicine, Cipla Imatinib Tablet.
